A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects

NCT05277350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

E.Coli Infections
Bloodstream Infection

Interventions

DRUG: SNIPR001
DRUG: Placebo

Sponsor

SNIPR Biome Aps.

Collaborators

[object Object]
[object Object]